#India #AI Innovation #Ahmedabad #Veeda Lifesciences #Mango Sciences

Veeda Lifesciences Partners with Mango Sciences for AI Innovation in Clinical Trials

Veeda Lifesciences, known globally as a pivotal player in the contract research organization (CRO) space, recently announced its significant step to enhance clinical trials by investing in Boston-based Mango Sciences, a cutting-edge healthcare AI and data analytics firm. This partnership marks a transformative moment in the clinical research landscape, aiming to streamline and improve the efficacy of clinical trial services.

Unleashing AI Potential in Clinical Trials

By integrating Mango Sciences' innovative Querent™ platform, Veeda intends to automate the identification of patients, expediting the recruitment process while ensuring a high quality of research. This strategic partnership seeks to bolster the representation of diverse and often underrepresented populations in clinical trials, addressing one of the most pressing needs in modern medical research. Together, they aim to not only refine the operational dynamics of clinical trials but also align with regulatory expectations and the evolving demands of pharmaceutical companies toward greater diversity.

Dr. Mahesh Bhalgat, Group CEO and Managing Director of Veeda Clinical Research Limited, emphasized the transformational potential of this partnership: "Our collaboration positions Veeda as an AI-driven oncology drug development organization, uniquely equipped to address the growing need for diversity in clinical trials." Dr. Bhalgat further added that they will be among only a few CROs possessing access to such proprietary AI technology in this niche sector, solidifying their position at the forefront of innovation in oncology research.

Elevating Operational Efficiency

The deployment of Mango's AI technologies is expected to enhance various aspects of clinical trial management. By harnessing data analytics and automation capabilities provided by the Querent™ platform, Veeda aims to streamline processes and enhance data management. This will lead to improved patient matching, more efficient trial designs, and expedited monitoring protocols, thus ultimately reducing both costs and timelines associated with clinical trial execution.

Dr. Mohit Misra, the Founder and CEO of Mango Sciences, highlighted their technological advancements, stating, "By integrating Large Language Models (LLMs) and Generative-AI within Querent™, we are poised to drive operational efficiencies and enrich real-world evidence, identifying the right drug for the right patient."

Competitive Edge in the CRO Market

Veeda's investment in Mango Sciences comes on the heels of its acquisition of Health Data Specialists (Heads), further solidifying its capabilities in oncology and ensuring access to diverse patient cohorts across India and Europe. This move not only enhances Veeda's operational efficiency but places it in a prime position to meet the increasing demands of the CRO market, which is ever-evolving alongside technological advancements.

The partnership also reflects Veeda's commitment to technology modernization and digital transformation—a strategic focus that is increasingly crucial in improving quality assurance and operational performance across its clinical research initiatives.

Moreover, the collaboration promotes a robust framework for gaining insights from data while supporting the representation of non-Caucasian populations in clinical trials, which has long been a shortcoming in many research endeavors. This approach is anticipated to significantly uplift the quality of data obtained during clinical trials, aligning with both ethical standards and market expectations.

About Veeda Lifesciences and Mango Sciences

Veeda Lifesciences offers a comprehensive suite of services across various stages of the drug development value chain, designed to support biotech and pharmaceutical companies. Their capabilities encompass everything from non-clinical and pre-clinical development to clinical pharmacology and extensive clinical trials. To learn more about their services, visit Veeda Lifesciences.

Mango Sciences is dedicated to revolutionizing patient care through advanced data analytics and innovative solutions, fostering improved patient access and comprehensive healthcare. For further information, check out Mango Sciences.

In conclusion, the collaboration between Veeda Lifesciences and Mango Sciences heralds a new era in clinical trials, where AI serves as a key driver in elevating research quality, representation, and operational efficiency, thus paving the way for innovative advancements in the healthcare sector.